Xydalba is administered as a 30-minute IV infusion1

No recommended dosage adjustment for many patient populations1

† Caution should be exercised when prescribing Xydalba to patients with moderate or severe hepatic impairment (Child-Pugh Class B or C) as no data are available to determine the appropriate dosing in these patients.

Dose adjustment for renal impairment is only necessary in patients with severe impairment (CrCl <30 ml/min) who are not on regular dialysis

Tables showing dose adjustment for renal impairment is only necessary in patients with severe impairment (CrCl
CrCl=creatinine clearance.
1 Xydalba SmPC;